Diffuse calvarial hemangiomatosis associated with hereditary hemorrhagic telangiectasia

…, MJ Hallisey, AS Muraki, DR Schellinger - … : American Journal of …, 1989 - ncbi.nlm.nih.gov
Discussion CNS involvement is said to occur in 27-29% of patients who have hereditary
hemorrhagic telangiectasia [3]. The association of calvarial hemangiomatosis with this disease …

Medical management vs mechanical thrombectomy for mild strokes: an international multicenter study and systematic review and meta-analysis

…, V Maus, A Siddiqui, M Waqas, PD Schellinger… - JAMA …, 2020 - jamanetwork.com
Dr Schellinger reported personal fees and other support from Boehringer Ingelheim and
personal fees from Medtronic and from Expert Witness for German Courts outside the submitted …

[HTML][HTML] Dabigatran for prevention of stroke after embolic stroke of undetermined source

…, M Odinak, JL Saver, PD Schellinger… - … England Journal of …, 2019 - Mass Medical Soc
Background Cryptogenic strokes constitute 20 to 30% of ischemic strokes, and most
cryptogenic strokes are considered to be embolic and of undetermined source. An earlier …

Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial

…, EC Unger, JC Grotta, PD Schellinger… - Annals of Neurology …, 2009 - Wiley Online Library
Dr Rubiera received a fellowship grant from the Instituto de Salud Carlos III and Instititut de
Dr Grotta has no disclosures. Dr Schellinger received speaker honoraria from Boehringer …

Intravenous thrombolysis prior to mechanical thrombectomy in large vessel occlusions

…, N Goyal, A Arthur, PD Schellinger… - Annals of …, 2019 - Wiley Online Library
… Arthur: Review of the manuscript for important intellectual content; Dr. Schellinger: Review
of the manuscript for important intellectual content; Dr. Köhrmann: Review of the manuscript …

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage

JB Kuramatsu, ST Gerner, PD Schellinger, J Glahn… - Jama, 2015 - jamanetwork.com
Dr Dohmen reported having received speaking fees from Bayer, UCB, Daiichi Sankyo,
and Pfizer. Dr Erbguth reported having received advisory board and speaking honoraria from …

Transcranial laser therapy in acute stroke treatment: results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial

W Hacke, PD Schellinger, GW Albers, NM Bornstein… - Stroke, 2014 - Am Heart Assoc
Dr Schellinger received fees and expenses from PhotoThera as member of the NEST 3 steering
committee. DrDr Bornstein received fees and expenses from PhotoThera as member of …

Association of surgical hematoma evacuation vs conservative treatment with functional outcome in patients with cerebellar intracerebral hemorrhage

…, AL Schubert, F Erbguth, M Nueckel, PD Schellinger… - Jama, 2019 - jamanetwork.com
Dr Schellinger reports receipt of personal fees from Boehringer Ingelheim and Daiichi
Sankyo during the conduct of the study; personal fees from Medtronic and German Courts (expert …

Risk of symptomatic intracerebral hemorrhage after intravenous thrombolysis in patients with acute ischemic stroke and high cerebral microbleed burden: a meta …

…, HP Mattle, AW Alexandrov, PD Schellinger… - JAMA …, 2016 - jamanetwork.com
Dr Nolte reports receiving consulting lectures and travel grants from Boehringer-Ingelheim.
Dr Schellinger reports receiving speaker fees, consulting fees, and travel grants from …

Acute stroke imaging research roadmap III imaging selection and outcomes in acute stroke reperfusion clinical trials: consensus recommendations and further …

…, DJ Fiorella, AJ Furlan, J Puig, PD Schellinger… - Stroke, 2016 - Am Heart Assoc
Dr Bammer is a co-founder and shareholder of iSchemaView, Inc, NIH RO1 EB002711. Dr
Campbell reports research … Dr Furlan is a consultant in Medtronic (no direct compensation). …